# GenSci143 in Participants With Advanced Solid Tumors

> **NCT07252414** · PHASE1 · RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 180 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** GenSci143 for injection

## Key facts

- **NCT ID:** NCT07252414
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-20
- **Primary completion:** 2028-10-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07252414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07252414, "GenSci143 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07252414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*